Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
暂无分享,去创建一个
D. Goodin | M. Filippi | L. Kappos | H. Hartung | G. Comi | A. Ascherio | S. Cook | D. Jeffery | C. Pohl | K. Fitzgerald | P. O'Connor | K. Munger | R. Sandbrink | K. Köchert | B. Arnason | G. Suárez
[1] Ludwig Kappos,et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. , 2014, JAMA neurology.
[2] M. Filippi,et al. Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes , 2014, Multiple sclerosis.
[3] M. Filippi,et al. Efficacy and safety of interferon beta-1b sc in older RRMS patients—a posthoc analysis of the BEYOND study , 2013, Journal of Neurology.
[4] G. Hallmans,et al. Vitamin D as a protective factor in multiple sclerosis , 2012, Neurology.
[5] C. McCulloch,et al. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis , 2012, Annals of neurology.
[6] W. Hop,et al. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis , 2012, Neurology.
[7] T. Holmøy,et al. Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment , 2012, Neurology.
[8] L. Kappos,et al. Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study , 2012, The Lancet Neurology.
[9] T. Pieber,et al. The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial , 2011, Diabetes/metabolism research and reviews.
[10] Daniela Pohl,et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study , 2011, The Lancet Neurology.
[11] P. Menheere,et al. Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis , 2010, PloS one.
[12] G. Abecasis,et al. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes , 2010, Genetic epidemiology.
[13] T. Dwyer,et al. Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis , 2010, Annals of neurology.
[14] J. M. Burton,et al. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis , 2010, Neurology.
[15] E. Mowry,et al. Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis , 2010, Annals of neurology.
[16] R. Jorde,et al. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. , 2010, Cytokine.
[17] H. DeLuca,et al. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production , 2010, Proceedings of the National Academy of Sciences.
[18] L. Meyerson,et al. Statistical methods for the analysis of relapse data in MS clinical trials , 2009, Journal of the Neurological Sciences.
[19] M. Filippi,et al. 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study , 2009, The Lancet Neurology.
[20] David H. Miller,et al. Health‐related quality of life in multiple sclerosis: effects of natalizumab , 2007, Annals of neurology.
[21] A. Ascherio,et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.
[22] G. Tenderich,et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.
[23] E. Frohman,et al. Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.
[24] W. Willett,et al. Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.
[25] F. Cosman,et al. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation , 2003, Journal of Neuroimmunology.
[26] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[27] R. Gill,et al. Cox's regression model for counting processes: a large sample study : (preprint) , 1982 .
[28] E. Giovannucci,et al. Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three U.S. cohorts , 2013 .